<i>FOXP2</i> confers oncogenic effects in prostate cancer through activating MET signalling

Xiaoquan Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanyang Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
bioRxiv (Cold Spring Harbor Laboratory)
July 6, 2022
10.1101/2022.07.06.498943
Cited by 0

Related Papers

A Gain-of-Function Mutation in Tnni2 Impeded Bone Development through Increasing Hif3a Expression in DA2B Mice
|PLoS Genetics|2014|38
FOXP2 confers oncogenic effects in prostate cancer
|eLife|2023|8